Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2020
Cerevel Therapeutics begins trading on Nasdaq
Cerevel Therapeutics began trading on the Nasdaq on October 28, 2020, after its business combination with Arya Sciences Acquisition Corp II. The article reports net proceeds of about $440 million from the transaction.